English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
NOVEL, FIRST-IN-CLASS, FATTY ACID SYNTHASE (FASN) INHIBITOR TVB-2640 DEMONSTRATES ROBUST CLINICAL EFFICACY AND SAFETY IN A GLOBAL PHASE 2 RANDOMIZED PLACEBO-CONTROLLED NASH TRIAL (FASCINATE-1) CONDUCTED IN THE US AND CHINA
Loomba, Rohit; Rinella, Mary E.; Harrison, Stephen A.; Wong, Vincent; Ratziu, Vlad; Gores, Gregory J.; Neuschwander-Tetri, Brent A.; Mohseni, Rizwana; Lucas, Kathryn Jean; Gutierrez, Julio A.; Perry, Robert; Rahimi, Robert S.; Trotter, James F.; Deng, Hong; Xie, Qing; Zhang, Jing; Wu, Lixian; You, Hong; Zhong, Bihui; Hou, JinLin; Yang, Yongfeng; Lu, Yan; He, Handan; Palmer, Melissa; Wu, Jinzi; Grimmer, Katharine; McCulloch, William; O'Farrell, Marie; Martins, Eduardo B.; Kemble, George
佛山市第一人民医院; 南方医科大学; 上海交通大学; 西北大学; 中山大学; 杭州师范大学; 1
72nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
2021-10
8
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试